HeartSciences (HSCSW) Invested Capital (2022 - 2026)

HeartSciences (HSCSW) has reported Invested Capital for 5 consecutive years, with $7.0 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital rose 152.88% year-over-year to $7.0 million; the trailing twelve-month figure through Apr 2026 stood at $7.0 million (up 152.88% YoY), and the FY2026 full-year result was $7.0 million, up 152.88% from the prior year.
• Invested Capital rose to $7.0 million in Q2 2026 per HSCSW's latest filing, from $2.8 million in the prior quarter.
• Across five years, Invested Capital topped out at $9.1 million in Q1 2024 and bottomed at -$232557.0 in Q4 2023.
• Historically, Invested Capital has averaged $3.8 million across 5 years, with a median of $4.0 million in 2022.
• The widest YoY moves for Invested Capital: up 7585.22% in 2023, down 110.51% in 2023.
• Over 5 years, Invested Capital stood at $2.2 million in 2022, then plunged by 110.51% to -$232557.0 in 2023, then soared by 2866.2% to $6.4 million in 2024, then tumbled by 57.15% to $2.8 million in 2025, then jumped by 152.88% to $7.0 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $7.0 million, $2.8 million, and $4.7 million for Q2 2026, Q4 2025, and Q4 2025 respectively.